Funding · Healthcare & Life Sciences

Ultrahuman raises $70 mn to expand health platform

By Startup Enthusiast · 1 September 2026

What they do

Ultrahuman builds wearable devices and software that track sleep, metabolic health, fitness, and blood biomarkers

The company raised $70 million in a new funding round led by Qualcomm Ventures with participation from Labcorp and others

The fresh capital will accelerate research and development across sensing, artificial intelligence, and clinical science

Wearable technology company Ultrahuman raised $70 million in new financing to expand its health intelligence platform.
The funding round was led by Qualcomm Ventures with participation from Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital.
The company plans to use the capital to accelerate research and development across sensing, artificial intelligence [computer systems able to perform tasks typically requiring human intelligence], miniaturised electronics, and clinical science.
Ultrahuman aims to evolve from a wearable health company into a human-computer interface company built around physiological data from the human body.
The company's ecosystem includes the Ultrahuman Ring, Blood Vision blood testing, continuous glucose monitoring devices, and the Jade real-time biointelligence system.
The funding follows strong financial growth, with the company reporting revenue of Rs 565 crore and a profit after tax of Rs 73 crore for the fiscal year ended March 2025.

The financing comes as Ultrahuman works to rebuild its presence in the United States following a patent dispute with Finnish rival Oura that led to an import ban on its smart rings.

Ultrahuman develops hardware and software products to track sleep, fitness, reproductive cycles, and blood markers to enhance healthspan and longevity.
Its flagship hardware products include the Ultrahuman Ring AIR and the newer pre-order Ultrahuman Ring PRO.
The company offers continuous glucose monitoring sensors such as M1 and M2 Live to track real-time glucose levels.
Blood Vision decodes over 100 blood markers into supplement plans and lifestyle tips.
The business generates revenue from device sales as well as a high-margin software subscription business that includes features like Cycle & Ovulation Pro and AFib Detection.

Expand health technology platform and global presence
Accelerate research and development across sensing, artificial intelligence, and clinical science

Product: Wearable smart rings, continuous glucose monitors, blood testing diagnostics, and health intelligence tracking software.
Customers: Consumers, athletes, and fitness-oriented individuals tracking metabolic health, sleep, and recovery.
How it makes money: Direct-to-consumer sales of wearable hardware combined with recurring subscription fees for health analytics and diagnostic tests.
What sets it apart: Multimodal platform integrating physiological, biochemical, and environmental biometrics with proprietary miniaturized electronics and health algorithms.